Biomarkers Market Growth Through 2030 Creates New Strategic Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Biomarkers Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The biomarkers market has experienced swift expansion in recent years, with projections indicating an increase from $77.42 billion in 2025 to $88.42 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.2%. This historical growth has been driven by progress in molecular biology, heightened investment in pharmaceutical research and development, a growing incidence of cancer, broader application in clinical trials, and an escalating need for targeted therapeutic approaches.
The biomarkers market is anticipated to experience significant expansion in the coming years, projected to reach $150.52 billion by 2030 with a compound annual growth rate (CAGR) of 14.2%. This growth is driven by factors such as the broadening of personalized treatment strategies, the increased utilization of liquid biopsy biomarkers, heightened regulatory backing for biomarker-based pharmaceuticals, progress in neurological disease research, and more extensive partnerships between pharmaceutical and diagnostic companies. Key trends shaping this period encompass rising applications of biomarkers in precision medicine, their deeper integration into drug discovery and development processes, growing prominence in oncology and chronic disease management, the expansion of companion diagnostics, and a heightened emphasis on early disease detection.
Download A Free Sample Report For Comprehensive Market Insights:
Biomarkers Market Development Factors: Which Trends Are Supporting Demand?
The rising prevalence of cardiac conditions is anticipated to drive expansion in the biomarkers market during the forecast period. Over recent years, there has been a significant surge in the application of biomarkers for managing heart disease patients. Currently, natriuretic peptides stand as the most widely employed biomarker, aiding in the identification of individuals suffering from heart failure. Additionally, circulating biomarkers, including high-sensitivity C-reactive protein, are utilized in diagnosing heart failure. Heart disease ranks as a leading cause of mortality across most racial and ethnic groups in the United States. This growing burden of cardiac ailments is expected to boost demand for biomarkers. For example, in September 2025, data from the British Heart Foundation, a UK-based charity, revealed that over 7.6 million people across the UK—more than 4 million men and over 3.6 million women—are living with cardiovascular disease. Projections suggest that, fueled by an aging population and enhanced survival rates, the number of affected individuals could increase by roughly 1 million by 2030 and by approximately 2 million by 2040. Consequently, the upsurge in heart diseases is fueling growth in the biomarkers market.
Biomarkers Market Segment Landscape: Which Areas Lead Market Development?
The biomarkers market covered in this report is segmented –
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers
Biomarkers Market Transformation Trends: Which Innovations Are Driving Change?
Major players in the biomarker industry are focusing on the creation of advanced solutions, including biomarker tests, designed to attract a broader customer base, boost sales volumes, and drive higher revenue. A biomarker test, often called a biomarker assay, refers to a diagnostic tool or laboratory method used to detect specific biological indicators—such as molecules, genes, or proteins—that offer insights into normal or disease-related processes within the body. As an illustration, Quest Diagnostics, a medical laboratory firm based in the United States, introduced a new biomarker test for prostate cancer in July 2023. This freshly launched tissue-based diagnostic service addresses a pressing medical need for tools that help differentiate potentially aggressive prostate cancer cases in men. The test was developed and validated by Quest through an intellectual property licensing agreement with Envision, enabling the use of Envision’s proprietary biomarker and immunohistochemistry technology. This technology incorporates Envision’s unique staining methods and innovative biomarkers labeled EV1, EV2, and EV3.
Biomarkers Market Industry Leaders And Market Competition
Major companies operating in the biomarkers market are Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.
Access The Complete Biomarkers Market Report:
Biomarkers Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
